Celebrating our Journey of Hope! Join us as we usher in PWSA | USA’s 50th Anniversary. Learn More

PWSA Blog

Federal Budget Proposals Could Undermine Critical Supports for Students with Prader-Willi Syndrome

Recent federal budget proposals may reshape how special education is funded and could pose real risks to students with Prader-Willi syndrome (PWS). A recent Undivided article, “Federal Budget Proposals That Could Impact Special Education,” notes several concerning shifts in policy (Undivided). While the administration is proposing $14.9 billion in IDEA Grants to States for fiscal year...

Aardvark Therapeutics HERO Trial: U.S. Sites Now Open

Aardvark Therapeutics recently launched HERO, a global Phase 3 clinical trial investigating ARD-101, an innovative, orally administered treatment designed to help reduce hyperphagia (excessive hunger) and food-seeking behaviors in individuals with Prader-Willi syndrome (PWS). This randomized, double-blind, placebo-controlled trial is an important step toward identifying a potential new treatment option for the PWS community, and...

Colorado PWS Families – Your Voices are Needed!

The Colorado Department of Health Care Policy & Financing will hold a Drug Utilization Review (DUR) Board meeting on August 12, 2025, from 1:00 to 5:00 p.m. (MT). This important meeting will review medications covered by Health First Colorado (Colorado’s Medicaid program) including those that could change the lives of individuals with Prader-Willi syndrome (PWS)....

Exciting News! PWS Included in FY26 Department of Defense Appropriations Bill for Medical Research

We are thrilled to share that Prader-Willi syndrome has been included in the Department of Defense’s (DOD) Peer-Reviewed Medical Research Program (PRMRP) in the 2026 Fiscal Year Defense Appropriations Bill. This is a MAJOR milestone for our community! This inclusion, passed out of the Senate Appropriations Committee, is the result of tireless advocacy efforts that...

Ask Nurse Lynn: Leptin and Hyperphagia

Question: Male, 36 years old, Deletion It was suggested to me by a doctor (not a PWS specialist) that those with PWS are deficient in the hormone leptin, and that replacing it could be an alternative way of helping with hyperphagia. Have you heard of leptin supplement as a treatment for hyperphagia? Nurse Lynn’s Response:...

photo/graphic of Nurse Lynn, the Prader-Willi syndrome (PWS) advice nurse

Ask Nurse Lynn: Risks of GLP-1 Medications

Question: Female, 40 years old, unknown subtype My daughter’s GP, and she herself, want to try Mounjaro injections for 6 months. She will be closely monitored by her nurse, her GP, her care team and family. She currently does not appear to have issues with gastroparesis but I want to prevent them by changing her...

photo collage of young adults and adults with Prader-Willi syndrome (PWS)

Building Our Social Skills (BOSS) Program Begins Again

PWSA | USA is excited to announce the return of the Building Our Social Skills (BOSS) program this fall. We know how important social development is for individuals with Prader-Willi syndrome, and how challenging it can be. BOSS, funded by FPWR was created to provide a supportive, structured space for participants to build communication skills, boost confidence,...

photo/graphic of Nurse Lynn, the Prader-Willi syndrome (PWS) advice nurse

Ask Nurse Lynn: Ocular Issues and Eye Patching

Question: Male, 15 months old, UPD subtype My son has esotropia and amblyopia primarily affecting his right eye but intermittently seen in his left eye as well. Surgical correction has been discussed and currently we have been instructed to patch his dominant eye (left) for two hours daily. We would like to pursue the interventions...

group photo of adults holding two large checks

PWSA | USA Helps Usher in New Era of Rare Disease Research with Launch of Florida’s Sunshine Genetics Act

Florida has officially launched the Sunshine Genetics Act, a first-of-its-kind initiative offering free, voluntary whole genome sequencing (WGS) for all newborns—and PWSA | USA was honored to stand at the forefront of this historic moment for rare disease families.  On July 9, 2025, leaders in science, medicine, and policy gathered at Florida State University’s Interdisciplinary...

Scroll to top